ArticleLaboratory investigation; a journal of technical methods and pathology2018

Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-κB signaling pathway.

Zhaohui Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.